Joanna Gardiner

1

Joanna Gardiner Managing Director Ovelle
Pharmaceuticals Presentation to conference
Female Entrepreneurship in the 21st Century

2
Ovelle Pharmaceuticals established in 1934with
full IMB cGMP pharmaceutical licenseSpecialise
in the formulation and manufacture of specialist
dry skin productsSME family owned
restructured with outside investment in 2000
3
My story in 2000.
Major restructuring required - losses low
moral Way forward required on succession Need
for medium term strategy Need for increased
sales Company producing low value added products
Need to streamline production Need to build
management team Improved financial management
needed Need to address negative margins
4
By 2004 !
5
By 2005.........
Turnover doubled Exports grew by 121 Positive
Margins elave no 1 brand since 2004 8 senior
managers (4 women) High Moral Strong Innovation
NPD Culture Two Enterprise RTIs completed 15 new
products
6
2006
Expansion phase into UK underway UK Boots
Listings June 2006 Launch into UK Independent
Pharmacies Entrepreneurial Marketing Strategy of
save your skin ! www.elave.ie www.greenpeace.org.u
k/Products/Toxics/
7
The challenge..

• The surplus society has a surplus of similar
  companies, employing similar people, with similar
  ideas, producing similar things, with similar
  prices and similar quality.
• Kjell Nordstrom- Funky Business

8
The challenge

every 25 minutes a new factory opens in
China Edward Gresser (Wall Street Journal).
9
The answer
Only the constant persuit of innovation can
ensure longterm success. Daniel Muzyka
10
The challenge ?
Why is female entrepreneurship low in Ireland by
comparison to the rest of Europe the US ?
11
Your attitude ?

• A new idea is delicate. It can be killed by a
  sneer or a yawn. It can be stabbed to death by a
  joke, or worried to death by a frown on the right
  mans brow Charles Browden.

12
Lifeis a challenge
What is for dinner ? Did you feed the dog ? I
need 1900 euro every month to have my three
lovely children properly minded. Moaning Ireland
?
13
(No Transcript)